Lack of Efficacy and Safety of Eculizumab for Treatment of Antibody-Mediated Rejection Following Renal Transplantation-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Lack of Efficacy and Safety of Eculizumab for Treatment of Antibody-Mediated Rejection Following Renal Transplantation

Published:2022-10 Issue:8 Volume:54 Page:2117-2124
ISSN:0041-1345
Container-title:Transplantation Proceedings
language:en
Short-container-title:Transplantation Proceedings

Author:

Heo Sujung,Park Youngchan,Lee Nagyeom,Kim Yanghyeon,Kim Ye Na,Shin Ho Sik,Jung Yeonsoon,Rim Hark,Rennke Helmut G.,Chandraker Anil

Funder

Alexion Pharmaceuticals

Ministry of Education

National Research Foundation of Korea

Publisher

Elsevier BV

Subject

Transplantation,Surgery

Reference36 articles.

1. Antibody-mediated rejection in kidney transplantation: a review of pathophysiology, diagnosis, and treatment options;Kim;Pharmacotherapy,2014

2. Diagnosis and management of antibody-mediated rejection: current status and novel approaches;Djamali;Am J Transplant,2014

3. Complement inhibition as potential new therapy for antibody-mediated rejection;Eskandary;Transpl Int,2016

4. Safety and long-term efficacy of eculizumab in a renal transplant patient with recurrent atypical hemolytic-uremic syndrome;Chatelet;Am J Transplant,2009

5. Disappearance of T cell-mediated rejection despite continued antibody-mediated rejection in late kidney transplant recipients;Halloran;J Am Soc Nephrol,2015

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The role of anticomplement therapy in the management of the kidney allograft;Clinical Transplantation;2024-03

2. Targeting the Complement Pathway in Kidney Transplantation;Journal of the American Society of Nephrology;2023-07-13

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3